Liver transplantation as a treatment for familial amyloidotic polyneuropathy
Mass spectrometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy
We also expect to initiate a Phase II study with ALN-TTR02 in familial amyloidotic polyneuropathy
, or FAP, patients in the second half of this year with the start of pivotal trials with ALN-TTR02 in 2013.
Familial amyloidotic polyneuropathy
(FAP)  type I is the most common dominantly inherited form of amyloidosis, i.
The data were presented at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy
being held November 20 - 22, 2011 in Kumamoto, Japan.
Transthyretin-related familial amyloidotic polyneuropathy
Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy
being held in Kumamoto, Japan from November 20-22, 2011.